慢性斑块状银屑病患者淋巴血液系统恶性肿瘤风险:系统综述与荟萃分析
该系统综述与荟萃分析纳入25项观察性队列研究、共2,501,652名受试者,评估慢性斑块状银屑病患者淋巴血液系统恶性肿瘤(LHM)风险。结果显示中重度斑块状银屑病患者LHM风险(HR 1.55;1.24-2.94)及淋巴瘤风险(HR 1.27;1.08-1.50)较一般人群显著升高,其中皮肤T细胞淋巴瘤风险升高最明显(HR 6.22;3.39-11.42)。
要点
- 中重度斑块状银屑病患者LHM风险较一般人群升高(HR 1.55;1.24-2.94)。
- 皮肤T细胞淋巴瘤风险升高最显著(HR 6.22;3.39-11.42)。
- 淋巴瘤、霍奇金淋巴瘤、非霍奇金淋巴瘤、多发性骨髓瘤及白血病风险均升高。
核心结论
- 银屑病患者LHM风险升高,尤其皮肤T细胞淋巴瘤,可能与系统性免疫抑制治疗暴露、合并症及持续免疫激活有关。
研究设计与样本
- 系统综述与荟萃分析,纳入25项观察性队列研究,共2,501,652名受试者,检索截至2021年2月28日,采用随机效应模型及Newcastle-Ottawa量表评估偏倚风险。
主要发现
- 中重度斑块状银屑病患者LHM风险HR 1.55(1.24-2.94),淋巴瘤风险HR 1.27(1.08-1.50)。
- 霍奇金淋巴瘤HR 1.71(1.27-2.30),非霍奇金淋巴瘤HR 1.27(1.08-1.50)。
- 多发性骨髓瘤HR 1.32(1.03-1.69),白血病HR 1.28(1.00-1.65)。
- 皮肤T细胞淋巴瘤HR 6.22(3.39-11.42)。
局限性
- LHM诊断可能存在 ascertainment bias(确认偏倚)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The association between chronic plaque psoriasis and lymphohematologic malignancies (LHMs) remains controversial. OBJECTIVE: To investigate the risk of LHMs in patients with psoriasis according to the best evidence. METHODS: A systematic review and meta-analysis of observational cohort studies was undertaken to assess the association of psoriasis with different LHMs. A literature search for relevant studies was performed on February 28, 2021. The random-effects model in conducting meta-analyses was applied. To evaluate the risk of bias, the Newcastle-Ottawa Scale was employed. RESULTS: A total of 25 observational studies were selected, comprising collectively 2,501,652 subjects. A significantly increased risk for LHM (hazard ratio [HR], 1.55; 1.24-2.94) and lymphoma (HR, 1.27; 1.08-1.50) in patients with moderate-to-severe plaque psoriasis compared to the general population was found. In detail, increased risks for Hodgkin lymphoma (HR, 1.71; 1.27-2.30), non-Hodgkin lymphoma (HR, 1.27; 1.08-1.50), multiple myeloma (HR, 1.32; 1.03-1.69), and leukemia (HR, 1.28; 1.00-1.65) were found. The risk of cutaneous T-cell lymphoma was markedly augmented in patients with psoriasis (HR, 6.22; 3.39-11.42). LIMITATIONS: Possible ascertainment bias related to the diagnosis of LHMs. CONCLUSION: The increased risk of LHMs, particularly cutaneous T-cell lymphoma, in patients with psoriasis could be related to exposure to systemic immunosuppressive therapies, comorbidities, and sustained immune activation, particularly in the skin.
引用
- Bellinato F, Gisondi P, Girolomoni G, et al. Risk of lymphohematologic malignancies in patients with chronic plaque psoriasis: A systematic review with meta-analysis. J Am Acad Dermatol. 2021. PMID: 34363908. doi:10.1016/j.jaad.2021.07.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。